{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:57:24Z","timestamp":1787061444455,"version":"build-2736575974"},"reference-count":65,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:00:00Z","timestamp":1633132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Schizophrenia is a chronic mental disorder that disturbs feelings and behavior. The symptoms of schizophrenia fall into three categories: positive, negative, and cognitive. Cognitive symptoms are characterized by memory loss or attentional deficits, and are especially difficult to treat. Thus, there is intense research into the development of new treatments for schizophrenia-related responses. One of the possible strategies is connected with cannabidiol (CBD), a cannabinoid compound. This research focuses on the role of CBD in different stages of memory (acquisition, consolidation, retrieval) connected with fear conditioning in the passive avoidance (PA) learning task in mice, as well as in the memory impairment typical of cognitive symptoms of schizophrenia. Memory impairment was provoked by an acute injection of the N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 (animal model of schizophrenia). Our results revealed that an acute injection of CBD (30 mg\/kg; intraperitoneally (i.p.) improved all phases of long-term fear memory in the PA test in mice. Moreover, the acute injection of non-effective doses of CBD (1 or 5 mg\/kg; i.p.) attenuated the memory impairment provoked by MK-801 (0.6 mg\/kg; i.p.) in the consolidation and retrieval stages of fear memory, but not in the acquisition of memory. The present findings confirm that CBD has a positive influence on memory and learning processes in mice, and reveals that this cannabinoid compound is able to attenuate memory impairment connected with hypofunction of glutamate transmission in a murine model of schizophrenia.<\/jats:p>","DOI":"10.3390\/molecules26195977","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T21:23:55Z","timestamp":1633728235000},"page":"5977","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Cannabidiol Attenuates MK-801-Induced Cognitive Symptoms of Schizophrenia in the Passive Avoidance Test in Mice"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9201-7181","authenticated-orcid":false,"given":"Marta","family":"Kruk-Slomka","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, 4a Chodzki Str., 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Biala","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, 4a Chodzki Str., 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.schres.2016.06.024","article-title":"Negative symptoms: History of the concept and their position in diagnosis of schizophrenia","volume":"186","author":"Dollfus","year":"2017","journal-title":"Schizophr. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0896-6273(00)00111-2","article-title":"Catching up on schizophrenia: Natural history and neurobiology","volume":"28","author":"Lewis","year":"2000","journal-title":"Neuron"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(02)00272-3","article-title":"Glutamate receptor function in learning and memory","volume":"140","author":"Riedel","year":"2003","journal-title":"Behav. Brain Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archneur.58.6.874","article-title":"Plasticity, hippocampal place cells, and cognitive maps","volume":"58","author":"Shapiro","year":"2001","journal-title":"Arch. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3109\/09540261.2012.703643","article-title":"Pharmacological treatment of schizophrenia","volume":"24","author":"Gadelha","year":"2012","journal-title":"Int. Rev. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1192\/bjp.184.2.110","article-title":"Causal association between cannabis and psychosis: Examination of the evidence","volume":"184","author":"Arseneault","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"ref_7","first-page":"14","article-title":"Pharmacology of cannabinoids","volume":"25","author":"Grotenhermen","year":"2004","journal-title":"Neuro Endocrinol. Lett."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jchromb.2007.02.016","article-title":"Simultaneous identification of 2-carboxy-tetrahydrocannabinol, tetrahydrocannabinol, cannabinol and cannabidiol in oral fluid","volume":"852","author":"Moore","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.2174\/138161212802884690","article-title":"Antipsychotic-like effects of cannabidiol and rimonabant: Systematic review of animal and human studies","volume":"18","author":"Roser","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.2174\/138161212802884735","article-title":"Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia","volume":"18","author":"Levin","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s13311-015-0382-6","article-title":"Cannabinoids and Schizophrenia: Risks and Therapeutic Potential","volume":"12","author":"Manseau","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.schres.2011.04.017","article-title":"Cannabis with high cannabidiol content is associated with fewer psychotic experiences","volume":"130","author":"Schubart","year":"2011","journal-title":"Schizophr. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1574889809666140307115532","article-title":"Therapeutic potential of cannabinoids in schizophrenia","volume":"9","author":"Kucerova","year":"2014","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.neubiorev.2008.03.012","article-title":"Models of schizophrenia in humans and animals based on inhibition of NMDA receptors","volume":"32","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbr.2015.12.023","article-title":"CB1 receptors in the formation of the different phases of memory-related processes in the inhibitory avoidance test in mice","volume":"301","author":"Biala","year":"2016","journal-title":"Behav. Brain Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neulet.2005.12.026","article-title":"WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors","volume":"397","author":"Pamplona","year":"2006","journal-title":"Neurosci. Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0014-2999(00)00615-4","article-title":"SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats","volume":"404","author":"Lichtman","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neulet.2005.01.049","article-title":"The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze","volume":"380","author":"Takahashi","year":"2005","journal-title":"Neurosci. Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta 9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.phrs.2016.01.033","article-title":"Cannabidiol, neuroprotection and neuropsychiatric disorders","volume":"112","author":"Campos","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.neubiorev.2016.11.012","article-title":"A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia","volume":"72","author":"Osborne","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bbr.2006.05.016","article-title":"Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats","volume":"172","author":"Resstel","year":"2006","journal-title":"Behav. Brain Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2009.09.045","article-title":"Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats","volume":"207","author":"Lemos","year":"2010","journal-title":"Behav. Brain Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fphar.2016.00454","article-title":"Cannabidiol regulation of learned fear: Implications for treating anxiety-related disorders","volume":"7","author":"Jurkus","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00213-011-2566-z","article-title":"Anxiogenic-like effects of chronic cannabidiol administration in rats","volume":"221","author":"ElBatsh","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s00213-014-3478-5","article-title":"Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe\/PS1\u2206E9 mice","volume":"231","author":"Cheng","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/npp.2012.63","article-title":"On disruption of fear memory by reconsolidation blockade: Evidence from cannabidiol treatment","volume":"37","author":"Stern","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.euroneuro.2015.02.001","article-title":"\u03949-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption","volume":"25","author":"Stern","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/bph.12199","article-title":"Cannabidiol attenuates deficits of visuolspatial associative memory induced by \u03949tetrahydrocannabinol","volume":"170","author":"Wright","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/npp.2017.40","article-title":"Improved social interaction, recognition and working memory with cannabidiol treatment in a prenatal infection (poly I:C) rat model","volume":"42","author":"Osborne","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00213-011-2449-3","article-title":"Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders","volume":"219","author":"Fagherazzi","year":"2012","journal-title":"Psychopharmacology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1177\/0269881112441865","article-title":"Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats","volume":"26","author":"Gururajan","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.npp.1300838","article-title":"Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice","volume":"31","author":"Long","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.schres.2015.01.015","article-title":"Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol","volume":"164","author":"Gomes","year":"2015","journal-title":"Schizophr. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/FBP.0000000000000178","article-title":"MK-801-induced deficits in social recognition in rats: Reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiol","volume":"26","author":"Deiana","year":"2015","journal-title":"Behav. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.neuropharm.2004.08.009","article-title":"Differential effects of THC- and CBD-rich cannabis-extracts on working memory in rats","volume":"47","author":"Fadda","year":"2004","journal-title":"Neuropharmacology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human Cannabinoid Pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem. Biodivers."},{"key":"ref_40","first-page":"169","article-title":"The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: Implications in psychosis and schizophrenia","volume":"4","year":"2014","journal-title":"Front. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: Effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.euroneuro.2013.11.002","article-title":"Cannabidiol as a potential treatment for psychosis","volume":"24","author":"Schubart","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (\u2212) Delta-9-tetrahydrocannabinol are neuroprotective","volume":"95","author":"Hampson","year":"1998","journal-title":"PNAS"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(01)00287-1","article-title":"Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus","volume":"106","author":"Hajos","year":"2001","journal-title":"Neuroscience"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.108.147181","article-title":"Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative\/nitrosative stress, inflammation, and cell death","volume":"328","author":"Pan","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1152\/ajpheart.00236.2007","article-title":"Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption","volume":"293","author":"Rajesh","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1124\/jpet.105.085779","article-title":"Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity","volume":"314","author":"Hamelink","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"12064","DOI":"10.1038\/s41598-017-10924-8","article-title":"Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/bs.apha.2017.04.001","article-title":"Actions and Regulation of Ionotropic Cannabinoid Receptors","volume":"80","author":"Nabissi","year":"2017","journal-title":"Adv. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"16546","DOI":"10.1074\/jbc.RA118.004929","article-title":"Inhibitory effects of cannabidiol on voltage-dependent sodium currents","volume":"293","author":"Ghovanloo","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1111\/bph.13724","article-title":"Cannabidiol regulation of emotion and emotional memory processing: Relevance for treating anxiety-related and substance abuse disorders","volume":"174","author":"Lee","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","article-title":"Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain","volume":"160","author":"McLaughlin","year":"2019","journal-title":"Pain"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.bmc.2015.01.059","article-title":"Cannabidiol (CBD) and its analogs: A review of their effects on inflammation","volume":"23","author":"Burstein","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/j.1476-5381.2011.01621.x","article-title":"Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus","volume":"165","author":"Rock","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neuropharm.2011.02.016","article-title":"Modulation of the Serotonin System by Endocannabinoid Signaling","volume":"61","year":"2011","journal-title":"Neuropharmacology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bpj.2017.03.037","article-title":"Antioxidant and membrane binding properties of serotonin protect lipids from oxidation","volume":"112","author":"Azouzi","year":"2017","journal-title":"Biophys. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/FBP.0000000000000247","article-title":"The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer\u2019s disease","volume":"28","author":"Karl","year":"2017","journal-title":"Behav. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1007\/s12035-019-1596-0","article-title":"Effects of Fatty Acid Amide Hydrolase Inhibitors Acute Administration on the Positive and Cognitive Symptoms of Schizophrenia in Mice","volume":"56","author":"Banaszkiewicz","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s12640-016-9662-0","article-title":"The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced byMK-801","volume":"30","author":"Budzynska","year":"2016","journal-title":"Neurotox. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0021-5198(19)43097-7","article-title":"Impairment of passive avoidance performance in SART-stressed mice and the action of drugs","volume":"49","author":"Nishimura","year":"1989","journal-title":"Jpn. J. Pharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2011.08.006","article-title":"Involvement of nitric oxide in granisetron improving effect on scopolamine-induced memory impairment in mice","volume":"1429","author":"Zakeri","year":"2012","journal-title":"Brain Res. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3922\/j.psns.2010.2.013","article-title":"Effects of curcumin on pentylenetetrazole-induced anxiety-like behaviors and associated changes in cognition and monoamine levels","volume":"3","author":"Chimakurthy","year":"2010","journal-title":"Psychol. Neurosci."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/19\/5977\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:08:46Z","timestamp":1760166526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/19\/5977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,2]]},"references-count":65,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["molecules26195977"],"URL":"https:\/\/doi.org\/10.3390\/molecules26195977","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,2]]}}}